|
Perceptual Disorders
|
C10.597.606.762 |
|
|
Neurobehavioral Manifestations
|
C10.597.606 |
|
|
Vascular Headaches
|
C10.228.140.546.699.500 |
|
|
Headache Disorders, Secondary
|
C10.228.140.546.699 |
|
|
rhoB GTP-Binding Protein
|
D12.776.476.525.700.300 |
|
|
rho GTP-Binding Proteins
|
D12.776.476.525.700 |
|
|
Chromosomes, Artificial, P1 Bacteriophage
|
G05.360.337.249.195 |
|
|
E2F3 Transcription Factor
|
D12.776.930.211.750 |
|
|
Chromosomes, Artificial, Mammalian
|
G05.360.337.249.190 |
|
|
Codeine
|
D03.605.497.607.204 |
|
|
Morphine Derivatives
|
D03.605.497.607 |
|
|
Hand Strength
|
G11.427.560.500 |
|
|
Muscle Strength
|
G11.427.560 |
|
|
Metalloporphyrins
|
D03.633.400.909.500.640 |
|
|
Porphyrins
|
D03.633.400.909.500 |
|
|
Transcription Factor RelB
|
D12.776.660.600.500 |
|
|
NF-kappa B
|
D12.776.660.600 |
|
|
Aquatic Organisms
|
B05.080 |
|
|
Benzeneacetamides
|
D044482 |
[Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.
] |
|
Intestinal Polyposis
|
D044483 |
[The growth of INTESTINAL POLYPS. Growth processes include neoplastic (ADENOMA and CARCINOMA) and non-neoplastic (hyperplastic, mucosal, inflammatory, and other polyps).
, A nonfamilial polyposis syndrome that is characterized by the presence of diffuse gastrointestinal polyposis, DIARRHEA, and PROTEIN-LOSING ENTEROPATHY. It was first reported by Cronkhite and Canada in 1955.
] |
